SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,370,000 | +2.2% | 24,304 | -2.8% | 0.05% | 0.0% |
| Q4 2014 | $2,320,000 | +37.1% | 25,004 | +1.6% | 0.05% | +30.0% |
| Q3 2014 | $1,692,000 | -34.4% | 24,607 | 0.0% | 0.04% | -33.3% |
| Q2 2014 | $2,579,000 | +19.1% | 24,607 | -5.7% | 0.06% | +15.4% |
| Q1 2014 | $2,165,000 | +81.8% | 26,096 | +41.9% | 0.05% | +79.3% |
| Q4 2013 | $1,191,000 | +3.8% | 18,396 | +1.5% | 0.03% | -6.5% |
| Q3 2013 | $1,147,000 | +54.6% | 18,118 | +2.6% | 0.03% | +40.9% |
| Q2 2013 | $742,000 | – | 17,661 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |